Karsten Bjerre

Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study

Michael Andersson, Elisabeth Lidbrink, Karsten Bjerre et al. · Journal of Clinical Oncology · 2010 · 294 citations

Medicine, Oncology, Pharmacology +17

The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise

Susanne Möller, Maj‐Britt Jensen, Bent Ejlertsen et al. · Acta Oncologica · 2008 · 280 citations · Full text

Medicine, Oncology, Breast Oncology +10

Recurrence pattern and prognosis in low-risk breast cancer patients – Data from the DBCG 89-A programme

Peer Christiansen, N.N. Al-Suliman, Karsten Bjerre et al. · Acta Oncologica · 2008 · 64 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Mortality Rates Among Early-Stage Hormone Receptor-Positive Breast Cancer Patients: A Population-Based Cohort Study in Denmark

Peer Christiansen, Karsten Bjerre, Bent Ejlertsen et al. · JNCI Journal of the National Cancer Institute · 2011 · 63 citations · Full text

Medicine, Endocrinology, Oncology +15

Epidemiological and microbiological investigation of a large increase in vibriosis, northern Europe, 2018

Ettore Amato, Daniel Thomas‐López, Marius Linkevičius et al. · Eurosurveillance · 2022 · 51 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17